In this article:

Due to the pandemic’s push to decentralized trial models, the historically paper-based method of collecting consent on paper brings a new host of challenges. As the shift to virtual trials shows persisting promise, the critical first step in any trial: the informed consent process, must also be examined.

Electronic consent technology aims to improve communication and clinical trial efficiency by presenting information to remote participants in a more easily digestible format. A recent study found that with a paper consent, research participants recalled about 58% of the material in informed consent documents, while 75% recalled information accurately when viewed in an eConsent format.

Electronic consent provides a new way to communicate with decentralized trial participants remotely, while meeting safety and regulatory requirements. Download our article to learn more, and to help determine if your consent process is ready for the move to virtual trials.